Article
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity.
Human molecular genetics - 1 Nov 2012
Stocco Gabriele, Yang Wenjian, Crews Kristine R, Thierfelder William E, Decorti Giuliana, Londero Margherita, Franca Raffaella, Rabusin Marco, Valsecchi Maria Grazia, Pei Deqing, Cheng Cheng, Paugh Steven W, Ramsey Laura B, Diouf Barthelemy, McCorkle Joseph Robert, Jones Terreia S, Pui Ching-Hon, Relling Mary V, Evans William E
Abstract excerpt
Treatment-related toxicity can be life-threatening and is the primary cause of interruption or discontinuation of chemotherapy for acute lymphoblastic leukemia (ALL), leading to an increased risk of relapse. Mercaptopurine is an essential component of continuation therapy in all ALL treatment protocols worldwide. Genetic polymorphisms in thiopurine S-methyltransferase (TPMT) are known to have a marked effect on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
